TOP

Current Issue

Case Report
Salvage UCBT with Short-Term Melphalan-based Reduced-Intensity Conditioning for Primary Graft Failure after Upfront UCBT for Fulminant Aplastic Anemia
Mari Morita-Fujita, Tomohiro Yabushita, Satoshi Yoshioka, Nobuhiro Hiramoto, Takayuki Ishikawa
Volume 8 (2025) Issue 2 No.1 Pages 190-194
Submitted: October 3, 2024
Accepted: February 3, 2025
Published online: March 28, 2025
Issued online: May 25, 2025
Case Report
PYODERMA GANGRENOSUM WITH NON-PSEUDOMONAL ECTHYMA GANGRENOSUM IN MYELODYSPLASTIC SYNDROME TREATED WITH ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Christine Faith V. Tan, Lynn B. Bonifacio, Minette Claire O. Rosario, Adolfo C. Parayno
Volume 8 (2025) Issue 2 No.2 Pages 195-199
Submitted: October 20, 2024
Accepted: February 24, 2025
Published online: May 9, 2025
Issued online: May 25, 2025
Original Article
PD-1 inhibitor in patients with minimal residual disease who failed donor lymphocyte infusion or interferon after allogeneic haematopoietic stem cell transplantation
Ling Ma, Si-Qi Li, Wei Han, Hai-Xia Fu, Yao Chen, Rui Ma, Yu-Hong Chen, Xiao-Hui Zhang, Lan-Ping Xu, Yu Wang, Chen-Hua Yan, Feng-Rong Wang, Xiao-Dong Mo, Xiao-Jun Huang, Yu-Qian Sun
Volume 8 (2025) Issue 2 No.3 Pages 200-209
Submitted: November 15, 2024
Accepted: January 31, 2025
Published online: May 25, 2025
Issued online: May 25, 2025
Original Article
Tyrosine kinase inhibitor-related factors pre-disposing to post-transplant thrombotic microangiopathy in patients with CML and Ph+ acute leukemias
Sachin Punatar, Komal Kumbhalwar, Siddhesh A Kalantri, Anant Gokarn, Lingaraj Nayak, Akanksha Chichra, Sumeet Mirgh, Nishant Jindal, Libin Mathew, Sadhana Kannan, Navin Khattry
Volume 8 (2025) Issue 2 No.4 Pages 210-216
Submitted: October 21, 2024
Accepted: January 11, 2025
Published online: May 25, 2025
Issued online: May 25, 2025

Online First

Corrigendum to: Impact of the COVID-19 outbreak on the field of hematopoietic cell transplantation in the Asia-Pacific region: APBMT Activity Survey 2020/2021 [Blood Cell Therapy. 2024; 7(4): 129-137. doi:10.31547/bct-2024-020]
Minako Iida1, Aloysius Ho2, Xiao Jun Huang3, Kaiyan Liu3, Meng Lv3, He Huang4, Yachiyo Kuwatsuka5, Joon Ho Moon6, Yoon Seok Choi7, Jong Wook Lee8, Navin Khattry9, Kavitha M. Lakshmi10, Leonie Wilcox11, Amir Ali Hamidieh12, Maryam Behfar13, Bor-Sheng Ko14, Kim Wah Ho15, Gin Gin Gan16, Udomsak Bunworasate17, Suradej Hongeng18, Usanarat Anurathapan18, Tasneem Farzana19, Joycelyn Sim20, Vincent Lee21, Man Kit Garret Leung20, Phu Chi Dung22, Van Man Huynh22, Wasantha Rathnayake23, Prasad Abeysinghe24, Marjorie Rose Bravo25, Teresita Dumagay26, Aye Aye Gyi27, Damai Santosa28, Desta Ardini28, Bishesh Sharma Poudyal29, Mafruha Akter30, Khishigjargal Batshkh31, Mikhail Drokov32, Chi-Cheng Li33, Shinichiro Okamoto34, Alok Srivastava10, Anthony Dodds35, Yoshiko Atsuta36,
Published online: June 6, 2025
REAL-WORLD OUTCOMES OF STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE TREATED WITH RUXOLITINIB
Archita Ravindranath1, Sushil Selvarajan1, Sharon Lionel1, Anup Joseph Devasia1, Anu Korula1, Fouzia N Aboobacker1, Kavitha M Lakshmi1, Poonkuzhali Balasubramanian1, Biju George1, Vikram Mathews1, Aby Abraham1, Uday Kulkarni1
Submitted: November 12, 2024
Accepted: January 14, 2025
Published online: June 27, 2025

Search

Volume / Issue
Article Type
Author
Search word

News

Online ISSN:2432-7026